IPO
-
-
-
-
-
-
-
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022
-
-
-
-
-
-
-
RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelXâ„¢ for Diagnosing Fast-Progressing Kidney Disease
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

